
Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer
Zou, Ling-jiao, Xiang, Qiu-ping, Xue, Xiao-qian, Zhang, Cheng, Li, Chen-chang, Wang, Chao, Li, Qiu, Wang, Rui, Wu, Shuang, Zhou, Yu-lai, Zhang, Yan, Xu, YongLangue:
english
Journal:
Acta Pharmacologica Sinica
DOI:
10.1038/s41401-019-0237-5
Date:
May, 2019
Fichier:
PDF, 4.49 MB
english, 2019